Added to YB: 2019-01-16
Pitch date: 2019-01-16
GTHX [bullish]
G1 Therapeutics, Inc.
-63.61%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
G1 Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer in the United States.
Market Cap
$378.2M
Pitch Price
$19.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
-10.18
P/E
-8.32
EV/Sales
6.28
Sector
Biotechnology
Category
N/A
Show full summary:
G1 THERAPEUTICS INC GTHX
A summary for this pitch has not been created yet.
Read full article (0 min)